Manipal Health Enterprises is moving closer to what could be the largest hospital IPO India has ever seen. The Temasek-backed Bengaluru chain is set to kick off investor roadshows as early as next week for an issue targeting north of $1 billion in proceeds, with management eyeing a valuation of around $12 billion. The two-week marketing window will cover both domestic and international investors.
Issue structure
Manipal filed its DRHP with SEBI on March 23, 2026, setting the formal clock ticking on its market debut. The offering combines a fresh issue of Rs 8,000 crore with an OFS of up to 4.32 crore shares by existing investors. Temasek (through Imperius Healthcare Investments), Manipal Education and Medical Group, TPG and Mubadala are among those paring stakes, making this a marquee exit for some of the biggest names in global private capital.
The book is being run by Kotak Mahindra Capital, Axis Bank, Goldman Sachs, JPMorgan and Jefferies. Shares will list on both BSE and NSE.
Where the money goes
The fresh issue isn't about funding growth, it's about cleaning up the balance sheet. Of the Rs 8,000 crore being raised, Rs 5,378 crore will go toward repaying borrowings at material subsidiary Manipal Hospitals Private Limited. Another Rs 574 crore is earmarked to mop up the remaining minority stake in Sahyadri Hospitals, Maharashtra's largest hospital chain that Manipal recently picked up from Ontario Teachers' Pension Plan.
As of January 31, 2026, consolidated borrowings stood at Rs 10,612.79 crore. So roughly half the debt pile gets wiped out post-listing, which should meaningfully lift the bottom line.
Scale and financials
Manipal isn't a small player. FY25 revenue came in at Rs 8,242 crore with PAT of Rs 1,081.67 crore. The chain runs 38 hospitals and treated 7.19 million patients last year. It recently overtook Apollo Hospitals in total bed capacity, a milestone the management has been chasing for a while.
On annualised FY26 numbers, revenue is tracking around Rs 9,426 crore with PAT of Rs 1,143 crore.
What this means for the sector
At a $12 billion valuation, Manipal would leapfrog Max Healthcare as India's most valuable listed hospital operator. It would also reset the benchmark for what a healthcare IPO can fetch in India. With private healthcare spending on a long upward trajectory and institutional flows into hospital stocks picking up, the listing fits a broader rerating story for the sector.
For retail investors, this is one to watch closely. Hospital IPOs tend to attract heavy QIB demand because of the long-duration cash flow profile, and Manipal's scale, debt cleanup and recent bed-count crown give it a strong narrative going into roadshows. Grey market signals haven't shown up yet, but they'll be worth tracking once anchor allocations open.
FAQs
When is the Manipal Hospitals IPO? Roadshows start as early as next week. The DRHP was filed with SEBI on March 23, 2026. Final dates depend on SEBI clearance and market conditions.
What is the size of the Manipal IPO? The issue targets over $1 billion in proceeds, with Rs 8,000 crore in fresh issue plus an OFS of up to 4.32 crore shares.
What valuation is Manipal targeting? Around $12 billion, which would make it India's most valuable listed hospital chain.
Who are the selling shareholders? Temasek, Manipal Education and Medical Group, TPG, and Mubadala are among the investors exiting partially through the OFS.
Where will the proceeds go? Mostly debt repayment. Rs 5,378 crore goes to clearing borrowings at the hospital subsidiary, and Rs 574 crore funds the Sahyadri minority buyout.
Discussion 0
No comments yet
Be the first to share your thoughts!